Henry Ji
Usihlalo, uMongameli kanye ne-CEO
- Iminyaka engu-25+ yesipiliyoni embonini ye-biotechnology nesayensi yezempilo
- UDkt. Ji wasungula i-Sorrento futhi usebenze njengomqondisi kusukela ngo-2006, i-CEO kanye noMongameli kusukela ngo-2012, kanye noSihlalo kusukela ngo-2017.
- Ngesikhathi esebenza e-Sorrento, uye wakha futhi wahola ukukhula okumangalisayo kwe-Sorrento ngokuthengwa nokuhlanganiswa okuhlanganisa i-Bioserv, i-Scilex Pharmaceuticals, i-Concortis Biotherapeutics, i-Levena Biopharma, i-LACEL, i-TNK Therapeutics, i-Virttu Biologics, i-Ark Animal Health, ne-Deliverysa Systems Lymphatic.
- Usebenze njengeSikhulu Esiphezulu Sezesayensi ye-Sorrento kusukela ngo-2008 kuya ku-2012 futhi njenge-CEO yayo yesikhashana kusukela ngo-2011 kuya ku-2012.
- Ngaphambi kuka-Sorrento, ubephethe izikhundla eziphezulu e-CombiMatrix, Stratagene futhi wasungula i-Stratagene Genomics, inkampani engaphansi kwe-Stratagene, futhi wasebenza njengoMongameli kanye noMphathi Omkhulu kanye noMqondisi weBhodi.
- I-BS kanye ne-Ph.D.
Vala u-X
Dorman Followwill
Director
- UMnu. Followwill, usebenze njengomqondisi kusukela ngoSepthemba 2017
- UbenguMphathi Omkhulu, I-Transformational Health e-Frost & Sullivan, inkampani yokubonisana yebhizinisi ebambe iqhaza ocwaningweni lwemakethe nokuhlaziya, ukubonisana ngamasu okukhula kanye nokuqeqeshwa kwezinkampani kuzo zonke izimboni eziningi, kusukela ngo-2016.
- Ngaphambi kwaleso sikhathi, wasebenza ezindimeni ezihlukahlukene e-Frost & Sullivan, kuhlanganise noMphathi weKomidi eliPhezulu eliphethe i-P & L yebhizinisi eYurophu, e-Israel nase-Afrika, kanye nozakwethu ophethe ibhizinisi le-Healthcare and Life Sciences eNyakatho Melika, kusukela ekuqaleni kokujoyina. UFrost & Sullivan ukusiza bathole umkhuba Wokubonisana ngoJanuwari 1988
- UMnu. Followwill uneminyaka engaphezu kuka-30 yobuholi benhlangano kanye nesipiliyoni sokubonisana nabaphathi, esebenze emaphrojekthini wokubonisana namakhulu kuzo zonke izifunda ezinkulu nakuzo zonke izigaba zezimboni eziningi, iphrojekthi ngayinye igxile esimisweni esibalulekile sokukhula.
- BA
Vala u-X
UKim D. Janda
Director
- UDkt. Janda usebenze njengomqondisi kusukela ngo-Ephreli 2012
- UDkt. Janda ube ngu-Ely R. Callaway, uSihlalo onguSolwazi Omncane eminyangweni yeKhemistry, i-Immunology kanye ne-Microbial Science e-The Scripps Research Institute ("TSRI") kusukela ngo-1996 futhi njengoMqondisi we-Worm Institute of Research and Medicine ( “WIRM”) e-TSRI kusukela ngo-2005. Ngaphezu kwalokho, uDkt. Janda usebenze njenge-Skaggs Scholar ngaphakathi kwe-Skaggs Institute of Chemical Biology, nayo e-TSRI, kusukela ngo-1996.
- Ushicilele izincwadi zokuqala ezingaphezu kuka-425 kumajenali abuyekezwe ngontanga futhi wasungula izinkampani ze-biotechnological i-CombiChem, i-Drug Abuse Sciences kanye ne-AIPartia uDkt. Janda ungumhleli womhleli we-“Bioorganic & Medicinal Chemistry”, “PLoS ONE” futhi uyasebenza, noma uke wasebenza. , emabhodini okuhlela amajenali amaningi kuhlanganise no-J. Comb. Chem., Chem. Izibuyekezo, J. Med. Chem., The Botulinum Journal, Bioorg. & ne-Med. I-Chem. Lett., kanye ne-Bioorg. & ne-Med. I-Chem
- Esikhathini esingaphezu kweminyaka engama-25, uDkt. Janda unikeze iminikelo eminingi futhi uthathwa njengomunye wososayensi bokuqala ukuhlanganisa izindlela zamakhemikhali nezebhayoloji zibe uhlelo oluhlangene locwaningo.
- UDkt. Janda usebenze ku-Scientific Advisory Boards of Materia kanye Nomnyango Wezemfundo wase-Singapore
- I-BS kanye ne-Ph.D.
Vala u-X
David Lemus
Director
- UMnu. Lemus usebenze njengomqondisi weNkampani kusukela ngoSepthemba 2017
- Njengamanje uyi-CEO ye-Ironshore Pharmaceuticals, Inc.
- Ukwengeza usebenza njengelungu lebhodi elingaphethe le-Silence Therapeutics (NASDAQ: SLN) kanye ne-BioHealth Innovation, Inc.
- Phambilini e-Sigma Tau Pharmaceuticals, Inc. kusukela ngo-2011-2015, usebenze njenge-CEO.
- Ukwengeza, uMnu. Lemus usebenze njenge-CFO kanye ne-Executive VP ye-MorphoSys AG kusukela ngo-1998-2011, ebeka inkampani esidlangalaleni ku-IPO yokuqala ye-biotech yaseJalimane.
- Ngaphambi kokuba abambe iqhaza ku-MorphoSys AG, ubenezikhundla ezehlukene zokuphatha okubalwa kuzo izinkampani iHoffman La Roche, Electrolux AB, kanye neLindt & Spruengli AG (Group Treasurer)
- BS, MS, MBA, CPA
Vala u-X
Jaisim Shah
Director
- UMnu. Shah usebenze njengomqondisi kusukela ngo-2013
- Iminyaka engu-25+ yesipiliyoni embonini yezemithi
- UMnu. Shah njengamanje usebenza njenge-CEO kanye noMongameli weScilex Holding and Scilex Pharmaceutical.
- Ngaphambi kukaScilex, usebenze njenge-CEO kanye noMongameli weSemnur Pharmaceuticals (etholwe ngabakwaScilex Pharmaceuticals) kusukela yasungulwa ngo-2013.
- Kusukela ngo-2011 kuya ku-2012, usebenze njengeSikhulu Esiphezulu Sebhizinisi le-Elevation Pharmaceuticals lapho egxile khona kwezezimali, ukuhlanganiswa nokuthengwa, kanye nokuthuthukiswa kwebhizinisi.
- Ngaphambi kwe-Elevation, uMnu. Shah wayenguMongameli weZelos Therapeutics, lapho ayegxile khona ekuxhaseni ngezimali nasekuthuthukiseni amabhizinisi.
- Ngaphambi kukaZelos, uMnu. Shah wayeyiPhini Likamongameli Omkhulu kanye Nesikhulu Esiyinhloko Sebhizinisi kwa-CytRx. Ngaphambilini, uMnu. Shah wayeyiSikhulu Sebhizinisi Esiyinhloko kwa-Facet Biotech kanye ne-PDL BioPharma lapho ephothule khona amalayisense amaningi/ukubambisana kanye namasu okuthengiselana.
- Ngaphambi kwe-PDL, uMnu. Shah wayeyiPhini Likamongameli Wezokumaketha Komhlaba wonke kwa-BMS lapho athola khona “Indondo Yomongameli” ngokuqeda ukusebenzisana okubaluleke kakhulu emlandweni wenkampani.
- MA kanye ne-MBA
Vala u-X
U-Alexander Wu
Director
- UDkt. Wu usebenze njengomqondisi kusukela ngo-Agasti 2016
- Njengamanje uphinde asebenze ku-BOD yeScilex Pharmaceutical kusukela ngo-2019
- UDkt. Wu wayengumsunguli ngokubambisana, i-CEO, uMongameli, kanye neSikhulu Esiphezulu Sezesayensi se-Crown Bioscience International, inkampani ehamba phambili emhlabeni jikelele yokutholwa kwezidakamizwa nezixazululo zentuthuko, ayisungula ngokuhlanganyela ngo-2006.
- Kusukela ngo-2004 kuya ku-2006, ubeyiChief Business Officer ye-Starvax International Inc. e-Beijing, e-China, inkampani ye-biotechnology egxile ku-oncology nezifo ezithathelwanayo.
- Kusukela ngo-2001 kuya ku-2004, ubeyibhange neBurrill & Company lapho ayeyinhloko ye-Asian Activities.
- BS, MS, MBA, kanye ne-Ph.D.
Vala u-X